Fri 15'th Jun 2018
VistaGen Therapeutics Inc Stock Analysis
Technical stock analysis for Fri 15'th Jun 2018
VistaGen Therapeutics Inc gained 1.35% in the last trading day, rising from $1.48 to $1.50 The price has been going up and down for this period, and there has been a 10.29% gain for the last 2 weeks. Volume fell in the last day by -169 452 shares, and in total, 521 037 shares bought and sold for approximately $0.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
|Shorts||1.36% ( 2018-05-31 )|
VistaGen Therapeutics Inc lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.54 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 27.15% during the next 3 months and, with 90% probability hold a price between $1.32 and $1.96 at the end of this period.
VistaGen Therapeutics Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.45 and $1.18. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday May 29, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 52 and the stock is currently not being overbought or oversold
Support & Resistance
VistaGen Therapeutics Inc finds support from accumulated volume at $1.49.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 7.75%. For the last week the stock has had a daily average volatility of 10.20%.
Our recommended stoploss: $1.42 (-5.41%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 13 days ago.)
Very Low Low Medium High Very High
VistaGen Therapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.
Trade VTGN CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder